Home
About Us
Management
Technology & Products
Electroceuticals®
EFFECT Trial
SofPulse® Electroceutical® Therapy
Scientific Studies
Patents
Investors
Overview
Regulation A Offering
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Contact
Home
About Us
Management
Technology & Products
Electroceuticals®
EFFECT Trial
SofPulse® Electroceutical® Therapy
Scientific Studies
Patents
Investors
Overview
Regulation A Offering
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
Contact
Management
Kodenbushi
Investors
Overview
Regulation A Offering
Regulation A Offering
News / Events
Press Releases
Email Alerts
Company Information
Profile
Management Team
Scientific Advisory Board
Presentations
IR Contacts
FAQ
Video
Financial Information
Quarterly Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Board of Directors
Email Alerts
Presentations
Tear Sheet
IR Contacts
RSS News Feed
Press Releases
All News
By Year:
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Oct 12, 2023 • 9:07 AM EDT
Endonovo's SofPulse® Secures Taiwan FDA Approval
Aug 22, 2023 • 9:07 AM EDT
Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution
Aug 8, 2023 • 9:03 AM EDT
Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update
Jun 7, 2023 • 9:07 AM EDT
Endonovo Pending Agreement to Develop Telehealth Division
May 2, 2023 • 9:03 AM EDT
Endonovo Launches SofPulse® into the Veterans Administration
Apr 25, 2023 • 9:07 AM EDT
Endonovo Reaches Out to Top Clinical Researchers to Collaborate on TBI Treatment Studies
Apr 13, 2023 • 9:07 AM EDT
Endonovo Announces Partnership with Former NFL Dallas Cowboy Defensive Lineman
Apr 10, 2023 • 12:01 PM EDT
Endonovo Announces Partnership with Santana Lead Singer Andy Vargas
Mar 29, 2023 • 9:07 AM EDT
Endonovo Announces Binding Letter of Intent to Sell SofPulse® Assets to Spin-Off Company
Mar 23, 2023 • 9:03 AM EDT
Endonovo’s SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in Taiwan
1
2
3
4
5
6
7
8
9
10
...16
Next >>
Show All